Track topics on Twitter Track topics that are important to you
With global operations in the U.S. , Scotland and Sweden, Viragen is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. Viragen is publicly traded on the American Stock Exchange (VRA). Viragen's majority-owned subsidiary, Viragen International, Inc., is publicly traded on the Over-The-Counter Bulletin Board (VGNI). Viragen currently employs 62 people with corporate facilities in Plantation, Florida (Headquarters) and research and manufacturing facilities in Edinburgh, Scotland and Umeå, Sweden.
865 SW 78th Avenue, Suite 100
United States of America
Phone: (954) 233-8746
Fax: (954) 233-1414
With global operations in the U.S. , Scotland and Sweden, Viragen is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based dr...
We have published hundreds of Viragen news stories on BioPortfolio along with dozens of Viragen Clinical Trials and PubMed Articles about Viragen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Viragen Companies in our database. You can also find out about relevant Viragen Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...